We found a decreasing trend of MVC in malignant when compared to borderline and benign, and it was significant with a p-value <0.05 but as of our knowledge not much studies have been conducted on MVC in endometrial cancers.
← all excerpts
Evaluation of the diagnostic utility of MCAM-1 (CD146) in a group of common gynecological cancers: A case-control study.
1
—
—